These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 15583700

  • 21. Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women.
    Peters WR, MacMurry JP, Walker J, Giese RJ, Comings DE.
    Obes Res; 2003 Mar; 11(3):415-9. PubMed ID: 12634439
    [Abstract] [Full Text] [Related]

  • 22. [Serum leptin and insulin resistance in obesity and effects of sibutramine on them].
    Wu J, Lei MX, Chen HL.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):605-7. PubMed ID: 15804071
    [Abstract] [Full Text] [Related]

  • 23. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
    Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K, Study Group SA, SAT Study.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
    [Abstract] [Full Text] [Related]

  • 24. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N, Ryan DH, Renz CL, Hewkin AC.
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [Abstract] [Full Text] [Related]

  • 25. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
    Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR.
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):829-37. PubMed ID: 17544870
    [Abstract] [Full Text] [Related]

  • 26. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS.
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [Abstract] [Full Text] [Related]

  • 27. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [Abstract] [Full Text] [Related]

  • 28. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, Torp-Pedersen C, Bacher HP, Shepherd GM, James WP, SCOUT Investigators.
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [Abstract] [Full Text] [Related]

  • 29. Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.
    Kaukua JK, Pekkarinen TA, Rissanen AM.
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):600-5. PubMed ID: 14770192
    [Abstract] [Full Text] [Related]

  • 30. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.
    Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL.
    JAMA; 2003 Apr 09; 289(14):1805-12. PubMed ID: 12684359
    [Abstract] [Full Text] [Related]

  • 31. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G, Cortinas L, Sánchez-Reyes L, Berber A.
    Int J Obes Relat Metab Disord; 2001 May 09; 25(5):741-7. PubMed ID: 11360159
    [Abstract] [Full Text] [Related]

  • 32. Categorical strategies based on subject characteristics of dietary restraint and physical activity, for weight maintenance.
    Vogels N, Westerterp-Plantenga MS.
    Int J Obes (Lond); 2005 Jul 09; 29(7):849-57. PubMed ID: 15917852
    [Abstract] [Full Text] [Related]

  • 33. The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.
    Porter JA, Raebel MA, Conner DA, Lanty FA, Vogel EA, Gay EC, Merenich JA.
    Am J Manag Care; 2004 Jun 09; 10(6):369-76. PubMed ID: 15209480
    [Abstract] [Full Text] [Related]

  • 34. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
    Wang TF, Pei D, Li JC, Tsai WC, Tsai CC, Yao CY, Chang ET, Hsieh MC, Su KY, Kuo SW.
    Int J Clin Pract; 2005 Jul 09; 59(7):746-50. PubMed ID: 15963197
    [Abstract] [Full Text] [Related]

  • 35. Sympathetic-leptin relationship in obesity: effect of weight loss.
    Quilliot D, Böhme P, Zannad F, Ziegler O.
    Metabolism; 2008 Apr 09; 57(4):555-62. PubMed ID: 18328360
    [Abstract] [Full Text] [Related]

  • 36. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN, Ribeiro Filho FF, Kohlmann NE, Gouvea Ferreira SR, Zanella MT.
    Diabetes Obes Metab; 2005 May 09; 7(3):246-53. PubMed ID: 15811141
    [Abstract] [Full Text] [Related]

  • 37. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
    Barratt R, Frost G, O'Boyle A, Millward J, Truby H.
    J Hum Nutr Diet; 2008 Jun 09; 21(3):248-55. PubMed ID: 18477180
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
    Daniels SR, Long B, Crow S, Styne D, Sothern M, Vargas-Rodriguez I, Harris L, Walch J, Jasinsky O, Cwik K, Hewkin A, Blakesley V, Sibutramine Adolescent Study Group.
    Pediatrics; 2007 Jul 09; 120(1):e147-57. PubMed ID: 17576783
    [Abstract] [Full Text] [Related]

  • 39. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C, SCOUT Executive Steering Committee, SCOUT investigators.
    Metabolism; 2009 Aug 09; 58(8):1109-15. PubMed ID: 19454355
    [Abstract] [Full Text] [Related]

  • 40. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T, Ucar E, Birden F, Yasar O.
    Diabetes Nutr Metab; 2004 Apr 09; 17(2):103-7. PubMed ID: 15244102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.